
The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients.


Healthcare

Registration & Networking

Welcome

Opening Keynote

PANEL: Workable Revenue Models for Digital Health Companies; a Case Study

PANEL: Could Digital Health = Better Outcomes for Underserved Populations?

Networking Break

Closing Comments

Networking Reception

MICHAEL GREELEY 

Co-Founder and General Partner

LYDIA KNAB 

Global Privacy Lead

PAM DIAMOND

Co-Founder & CMO

JOSEPH BONCORE 

Chief Executive Officer

SUSAN HARVEY, M.D. 

Vice President of Worldwide Medical Affairs

2022 Digital Health Impact

2022 Digital Health Impact by
MassBio

Review stats

Reviews

Event Anywhere

2022 Digital Health Impact by MassBio

Review stats

Reviews

Event Anywhere

2022 Digital Health Impact by
MassBio